Chemical name: (6R-trans)-6-(1,3-benzodioxol-5-yl)- 2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino [1′, 2′
Formula: C22H19N3O4
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

TADALISTA SUPER ACTIVE

Description: TADALISTA SUPER ACTIVE is a medication primarily used for the treatment of erectile dysfunction (ED) in men. Each pill contains 20 milligrams of the active ingredient Tadalafil.

Indications: TADALISTA SUPER ACTIVE, containing Tadalafil, is indicated for the management of erectile dysfunction, a condition characterized by the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It works by increasing blood flow to the penis during sexual stimulation, facilitating the achievement and maintenance of an erection.

Mechanism of Action: Tadalafil, the active substance in TADALISTA SUPER ACTIVE, belongs to a class of medications known as phosphodiesterase type 5 (PDE5) inhibitors. It works by inhibiting the enzyme PDE5, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. This results in smooth muscle relaxation, vasodilation, and increased blood flow to the penis, leading to an erection.

Administration: TADALISTA SUPER ACTIVE is administered orally, typically taken as needed, approximately 30 minutes to 1 hour before anticipated sexual activity. The dosage may vary depending on individual response and tolerability. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare provider.

Dosage and Treatment Plan: The typical dosage of TADALISTA SUPER ACTIVE is one pill (20 mg) taken as needed, approximately 30 minutes to 1 hour before sexual activity. It is not recommended to exceed one dose in a 24-hour period.

Side Effects: Common side effects associated with TADALISTA SUPER ACTIVE may include headache, flushing, indigestion, nasal congestion, dizziness, and visual disturbances. Rare but serious side effects may include priapism (prolonged erection lasting more than 4 hours), sudden hearing loss, and allergic reactions.

Precautions:

• TADALISTA SUPER ACTIVE should be used with caution in individuals with pre-existing medical conditions such as cardiovascular disease, liver or kidney dysfunction, or bleeding disorders.
• It is contraindicated in individuals taking nitrate medications for chest pain (angina) or alpha-blockers for hypertension, as concurrent use may lead to severe hypotension.
• TADALISTA SUPER ACTIVE is not recommended for use in women or individuals under the age of 18.

Consultation with a Healthcare Provider: Before using TADALISTA SUPER ACTIVE, individuals should consult with a healthcare provider or qualified medical professional, especially if they have underlying health conditions or are taking other medications. They can provide guidance on proper usage, dosage, and potential risks associated with the medication. It is essential to undergo regular monitoring and evaluation to ensure safety and efficacy during treatment.